FDA advisory panel

An FDA advisory panel yesterday endorsed removing the “black box” warning on hormone treatments for menopause that critics say have discouraged women for decades from using the pills and creams. Why it matters: The meeting highlighted an area of particular interest for FDA commissioner Marty Makary, who cited warnings about hormone therapy in his book “Blind Spots” […]